Patients who experience a nonaneurysmal subarachnoid hemorrhage differ from patients who suffer an aneurysmal subarachnoid hemorrhage in initial presentation (including neurological examination ...

The effect of a liberal red-cell transfusion strategy as compared with a restrictive strategy in patients during the critical care period after an aneurysmal subarachnoid hemorrhage is unclear.

Shelly Gill collapsed without warning in the driver's seat. Her devastated family was told she would die or suffer severe ...

Kurokawa et al. (1996) measured daily sodium and water balance and concentrations of ANP, ADH, and plasma renin activity (PRA) in 31 patients with aneurysmal SAH. Because ANP levels can be ...

Researchers have demonstrated that implementation of a liberal blood transfusion policy does not offer cognitive-neurological ...

Grace Therapeutics (GRCE) will be participating in the mid-year clinical meeting of the American Society of Health-System Pharmacists to be ...

KOL Event on aneurysmal Subarachnoid Hemorrhage (aSAH) Grace Therapeutics hosted a virtual key opinion leader (KOL) event on November 20, 2024. The event featured Abhishek Ray, MD (University ...

Satralizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Demyelinating Diseases.

Classic symptoms of aneurysm rupture and bleeding around the brain (subarachnoid hemorrhage) include but are not limited to the following: Nausea and vomiting Sudden severe headache, often described ...

A recent international clinical trial involving 850 patients has revealed that a liberal blood transfusion strategy ...

A large trial published in the New England Journal of Medicine is adding to the debate for patients who have had a kind of brain bleeding called aneurysmal subarachnoid hemorrhage (aSAH).

Clazosentan in Reducing Vasospasm-Related Morbidity and All-Cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping (CONSCIOUS-2) The aim of this ...